Your browser doesn't support javascript.
loading
Outcomes of a Phase II Study of Intraperitoneal Paclitaxel Plus Systemic Capecitabine and Oxaliplatin (XELOX) for Gastric Cancer with Peritoneal Metastases.
Chia, Daryl K A; Sundar, Raghav; Kim, Guowei; Ang, Jia Jun; Shabbir, Asim; So, Jimmy B Y; Yong, Wei Peng.
Afiliación
  • Chia DKA; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore.
  • Sundar R; Department of Haematology-Oncology, National University Cancer Institute National University Health System, Singapore, Singapore.
  • Kim G; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Ang JJ; The N.1 Institute for Health, National University of Singapore, Singapore, Singapore.
  • Shabbir A; Department of Surgery, University Surgical Cluster, National University Health System, Singapore, Singapore.
  • So JBY; Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
  • Yong WP; Division of Surgical Oncology, National University Cancer Institute, National University Health System, Singapore, Singapore.
Ann Surg Oncol ; 30(3): 1889-1890, 2023 03.
Article en En | MEDLINE | ID: mdl-36564654
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Peritoneales / Neoplasias Gástricas Límite: Humans Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Singapur
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Peritoneales / Neoplasias Gástricas Límite: Humans Idioma: En Revista: Ann Surg Oncol Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: Singapur